VEGFR-3 expression profiling by histology to classify patient population for the selective VEGFR-3 inhbitor EVT801

被引：0
|
作者：
Paillasse, Michael
Ancey, Pierre-Benoit
Badet, Gaelle
Gomez-Brouchet, Anne
Selves, Janik
Rochaix, Philippe
Battistella, Maxime
Lebbe, Celeste
Cassier, Philippe
Gomez-Roca, Carlos
Delord, Jean-Pierre
Whittaker, Mark
Davenne, Lise
Friend, John
Fitzgerald, Michael
Garner, James
Fons, Pierre
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1015
引用
收藏
页数：3
相关论文
共 50 条
  • [1] VEGFR-3 expression profiling by histology and mRNA signature to classify patient population for the selective VEGFR-3 inhibitor EVT801
    Gomez-Roca, C. A.
    Fons, P.
    Ancey, P. B.
    Cassier, P.
    Delord, J. P.
    Davenne, L.
    Fitzgerald, M.
    Mandron, M.
    Paillasse, M. R.
    Friend, J.
    Rochaix, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S235 - S236
  • [2] Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
    Paillasse, Michael R.
    Esquerre, Michael
    Bertrand, Florie A.
    Poussereau-Pomie, Celine
    Pichery, Melanie
    Visentin, Virgile
    Gueguen-Dorbes, Genevieve
    Gaujarengues, Florence
    Barron, Pauline
    Badet, Gaelle
    Briaux, Anne
    Ancey, Pierre-Benoit
    Sibrac, David
    Erdociain, Eric
    Oezcelik, Dennis
    Meneyrol, Jerome
    Martin, Valerie
    Gomez-Brouchet, Anne
    Selves, Janik
    Rochaix, Philippe
    Battistella, Maxime
    Lebbe, Celeste
    Delord, Jean-Pierre
    Dol-Gleizes, Frederique
    Bono, Francoise
    Blanc, Isabelle
    Alam, Antoine
    Hunneyball, Ian
    Whittaker, Mark
    Fons, Pierre
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (11): : 1504 - 1519
  • [3] EVT801, a novel selective VEGFR-3 inhibitor targeting tumor angiogenesis, started enrollment for its phase I first-in-human study.
    Roca, Carlos Gomez
    Cassier, Philippe
    Mandron, Marie
    Estrabaut, Myriam
    Delesque-Touchard, Nathalie
    Smith, Adam C.
    Klawitter, Amy
    Gentry, Leesa
    Fons, Pierre
    Paillasse, Michael R.
    Davenne, Lise
    Fitzgerald, Michael
    Garner, James
    Delord, Jean-Pierre
    CANCER RESEARCH, 2022, 82 (12)
  • [4] EVT801, a novel selective VEGFR-3 inhibitor targeting tumor angiogenesis, is pursuing dose escalation stage of phase I first-in-human study
    Gomez-Roca, Carlos
    Cassier, Philippe
    Fitzgerald, Michael
    Davenne, Lise
    Costantin, Cristina
    Rochaix, Philippe
    Delord, Jean-Pierre
    Friend, John
    Nizzardo, Andrea
    Tagliavini, Alessia
    Pergher, Marco
    Fons, Pierre
    Mandron, Marie
    CANCER RESEARCH, 2024, 84 (07)
  • [5] VEGFR-3 in adult angiogenesis
    Witmer, AN
    van Blijswijk, BC
    Dai, J
    Hofman, P
    Partanen, TA
    Vrensen, GFJM
    Schlingemann, RO
    JOURNAL OF PATHOLOGY, 2001, 195 (04): : 490 - 497
  • [6] Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma
    Filho, Adhemar Longatto
    Baltazar, Fatima
    Bedrossian, Carlos
    Michael, Claire
    Schmitt, Fernando C.
    DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (12) : 786 - 791
  • [7] EVT801: Standalone cancer immunotherapy in VEGFR3+ tumors and combination with immune checkpoint therapies in VEGFR3- tumors
    Esquerre, Michael
    Fons, Pierre
    Badet, Gaelle
    Barron, Pauline
    Kagan, Jeremy
    Alam, Antoine
    Meneyrol, Jerome
    Blanc, Isabelle
    Broussy, Roselyne
    Gaujarengues, Florence
    Lisztwan, Joanna
    Paillasse, Michael
    Whittaker, Mark
    Bono, Francoise
    CANCER RESEARCH, 2017, 77
  • [8] CLINICAL SIGNIFICANCE OF VEGFR-2 AND VEGFR-3 EXPRESSION IN OVARIAN CANCER PATIENTS
    Klasa-Mazurkiewicz, Dagmara
    Jarzab, Miroslaw
    Milczek, Tomasz
    Lipinska, Barbara
    Emerich, Janusz
    POLISH JOURNAL OF PATHOLOGY, 2011, 62 (01) : 31 - 40
  • [9] Milroy disease and the VEGFR-3 mutation phenotype
    Brice, G
    Child, AH
    Evans, A
    Bell, R
    Mansour, S
    Burnand, K
    Sarfarazi, M
    Jeffery, S
    Mortimer, P
    JOURNAL OF MEDICAL GENETICS, 2005, 42 (02) : 98 - 102
  • [10] Formation of the glomerular microvasculature is regulated by VEGFR-3
    Donnan, Michael D.
    Deb, Dilip K.
    Onay, Tuncer
    Scott, Rizaldy P.
    Ni, Eric
    Zhou, Yalu
    Quaggin, Susan E.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2023, 324 (01) : F91 - F105
12345